News | RIVM

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Corona crisis has limited impact on infant participation in National Immunisation Programme

Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.

More children vaccinated against mumps, measles, rubella and HPV

The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.

A pregnant woman can protect her baby against whooping cough with 22-week vaccination

From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.

Report on the developments of the National Immunisation Programme: stabilisation of participation and low level of disease

In the first six months of 2019, the number of notified meningococcal serogroup W (MenW) disease cases decreased in almost all age groups, after a continuous increase since 2015.

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.

Updated immunisation recommendation for measles: early vaccination before travel

A number of European countries are currently seeing outbreaks of measles. Before the start of the summer season, RIVM has therefore updated its immunisation recommendation for measles.

Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination

Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.

Vaccination against meningococcal disease starts for teens aged 14 to 18

This spring, about 860,000 young people in the Netherlands will receive an invitation for a vaccination against meningococcal disease.

Biosafety and Biosecurity on the Global Health Security Agenda

Since 2018, the Netherlands leads the way in the field of "Biosafety and Biosecurity" within the international Global Health Security Agenda (GHSA).